Beth Israel Deaconess Medical Center;Dana-Farber Cancer Institute, Inc.
发明人:
申请号：
EP10012392.6
公开号：
EP2336187A3
申请日:
2001.06.19
申请国别(地区):
EP
年份:
2012
代理人:
摘要：
The invention provides compounds and methods for the ex vivo or in vivo<； expansion of NK T cells, CD1d-reactive T cells, and J alpha Q<；+>； cells, and the modulation of their activities. These compounds and methods have diagnostic and therapeutic applications.
